Analyst Price Targets — CALA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| November 15, 2022 4:04 am | — | Leerink Partners | $2.00 | $2.82 | Benzinga | SVB Leerink Downgrades Calithera Biosciences to Market Perform, Lowers Price Target to $2 |
Latest News for CALA
Calithera Biosciences (NASDAQ:CALA) Stock Passes Above Fifty Day Moving Average – Time to Sell?
Calithera Biosciences, Inc. (NASDAQ: CALA - Get Free Report)'s stock price passed above its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $0.00 and traded as high as $0.0002. Calithera Biosciences shares last traded at $0.0002, with a volume of 235 shares trading hands. Calithera Biosciences
Marriott International Announces Changes to its Continent Leadership and a Strategic Realignment Across Key Regions
Unified structure for U.S., Canada & CALA under Satya Anand's leadership; Neal Jones to lead EMEA; Federico "Fede" Greppi to head CALA; retirements of Marriott veterans Liam Brown and Brian King announced. BETHESDA, Md.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CALA.
U.S. House Trading
No House trades found for CALA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.